An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19
| Autor: | Fu, Weihui, Liu, Yan, Liu, Li, Hu, Huiliang, Cheng, Xiaobo, Liu, Ping, Song, Zhigang, Zha, Lijun, Bai, Shimeng, Xu, Tingting, Yuan, Songhua, Lu, Fengru, Shang, Zhiying, Zhao, Yihong, Wang, Jing, Zhao, Jun, Ding, Longfei, Chen, Jun, Zhang, Lin, Zhu, Tongyu, Zhang, Xiaoyan, Lu, Hongzhou, Xu, Jianqing |
|---|---|
| Zdroj: | In EClinicalMedicine October 2020 27 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|